GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $84.38 $96.99 Friday, 19th Apr 2024 BPMC stock ended at $86.85. This is 2.31% less than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 6.23% from a day low at $84.62 to a day high of $89.90.
90 days $72.25 $100.98
52 weeks $43.89 $100.98

Historical Blueprint Medicines Corporation prices

Date Open High Low Close Volume
2024-04-19 $88.45 $89.90 $84.62 $86.85 786 370
2024-04-18 $87.93 $91.76 $86.56 $88.90 719 632
2024-04-17 $87.31 $89.69 $86.78 $88.38 727 990
2024-04-16 $84.51 $88.08 $84.44 $86.09 392 332
2024-04-15 $87.18 $87.84 $84.38 $85.18 506 376
2024-04-12 $92.59 $93.00 $87.06 $87.25 472 753
2024-04-11 $91.47 $92.55 $90.44 $92.25 385 529
2024-04-10 $88.13 $90.58 $84.55 $90.49 569 839
2024-04-09 $92.27 $93.93 $91.34 $92.20 710 321
2024-04-08 $92.33 $93.21 $90.57 $91.54 313 646
2024-04-05 $90.00 $91.76 $88.23 $91.65 464 748
2024-04-04 $93.21 $93.31 $90.63 $90.68 486 108
2024-04-03 $90.42 $93.30 $90.31 $92.23 500 111
2024-04-02 $94.18 $94.49 $90.50 $91.56 553 583
2024-04-01 $95.00 $96.99 $93.70 $96.42 455 556
2024-03-28 $95.00 $95.98 $93.75 $94.86 602 986
2024-03-27 $90.08 $94.91 $89.12 $94.79 557 253
2024-03-26 $89.53 $92.55 $88.26 $89.67 530 439
2024-03-25 $87.59 $89.58 $86.76 $88.22 331 391
2024-03-22 $89.91 $91.06 $87.04 $87.04 291 809
2024-03-21 $89.13 $91.81 $89.13 $90.05 747 809
2024-03-20 $87.12 $89.53 $84.81 $88.26 1 267 902
2024-03-19 $86.08 $89.45 $84.90 $87.97 1 491 824
2024-03-18 $90.86 $91.67 $86.10 $86.82 996 760
2024-03-15 $87.28 $90.75 $86.58 $90.50 1 120 059
Click to get the best stock tips daily for free!

About Blueprint Medicines Corporation

Blueprint Medicines Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibitor for the treatment of non-advanced SM and other mast cell disorders; and Fisogatinib, an orally avail... BPMC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT